Literature DB >> 9210614

Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis.

J Michel1, B Suc, F Montpeyroux, S Hachemanne, P Blanc, J Domergue, J Mouiel, C Gouillat, C Ducerf, J Saric, Y P Le Treut, G Fourtanier, J Escat.   

Abstract

BACKGROUND/AIMS: Currently, surgical treatment of hepatocellular carcinoma in patients with cirrhosis is not clearly defined. The objective of this study was, in patients with cirrhosis with hepatocellular carcinoma, to compare liver resection to transplantation assessed by patient survival and to determine whether the tumor recurrence might be influenced by prognostic factors.
METHODS: We have gathered all the available data from six French Medical Universities, for 215 patients with cirrhosis with hepatocellular carcinoma surgically treated either by liver resection (102) or by transplantation (113).
RESULTS: The overall 5-year survival rate was similar in the transplantation group and in the resection group (32% vs. 31%, p=0.7). However, the 5-year survival rate without recurrence was higher in the transplantation group than in the resection group (60% vs. 14%, p<0.001). Three independent prognostic factors influenced significantly the survival without recurrence: the surgical treatment by transplantation (p<0.001), the number of tumors (p<0.01) and the tumor size (p<0.001). With these factors we defined a prognostic index (Ip) which allowed assessment of the probability of survival without recurrence: Ip= (Xie. x 1.41)+(Nbr T. x 0.19)+(Size TV. x 0.16); Xie=surgical treatment (Xie=0 if transplantation, Xie=1 if resection), Nbr.T. and Size TV.=number of tumors and size of the most voluminous tumor, respectively, according to the histologic study.
CONCLUSIONS: These results and this prognostic index are encouraging for liver transplantation as treatment of hepatocellular carcinoma in selected patients with cirrhosis.

Entities:  

Mesh:

Year:  1997        PMID: 9210614     DOI: 10.1016/s0168-8278(97)80462-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  34 in total

Review 1.  Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.

Authors:  Clarence Nicholas Kotewall; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-08

2.  Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?

Authors:  Georgios C Sotiropoulos; Nina Drühe; George Sgourakis; Ernesto P Molmenti; Susanne Beckebaum; Hideo A Baba; Gerald Antoch; Philip Hilgard; Arnold Radtke; Fuat H Saner; Silvio Nadalin; Andreas Paul; Massimo Malagó; Christoph E Broelsch; Hauke Lang
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

3.  Orthotopic liver transplantation as a rescue operation for recurrent hepatocellular carcinoma after partial hepatectomy.

Authors:  Zhuo Shao; Rocio Lopez; Bo Shen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

4.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 5.  Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis.

Authors:  Mashaal Dhir; Elizabeth R Lyden; Lynette M Smith; Chandrakanth Are
Journal:  HPB (Oxford)       Date:  2012-06-19       Impact factor: 3.647

6.  Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

7.  Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.

Authors:  Wing Chiu Dai; See Ching Chan; Kenneth S H Chok; Tan To Cheung; William W Sharr; Albert C Y Chan; Simon H Y Tsang; James Y Y Fung; Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

8.  Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

Authors:  G B Klintmalm
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

9.  Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.

Authors:  Norifumi Harimoto; Tomoharu Yoshizumi; Yukiko Fujimoto; Takashi Motomura; Youhei Mano; Takeo Toshima; Shinji Itoh; Noboru Harada; Toru Ikegami; Hideaki Uchiyama; Yuji Soejima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

10.  Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection.

Authors:  Ramanathan M Seshadri; Siddesh Besur; David J Niemeyer; Megan Templin; Iain H McKillop; Ryan Z Swan; John B Martinie; Mark W Russo; David A Iannitti
Journal:  HPB (Oxford)       Date:  2014-06-25       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.